Search results
Results from the WOW.Com Content Network
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. [2] The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion (+2% vs 2022), across three business: "Medical Product and Therapies", "Heathcare ...
Baxter sold its BioPharma Solutions business in October for $4.25 billion to investment firms. The new company, Simtra, wants to expand. ... 800-290-4726 more ways to reach us. Sign in. Mail. 24/7 ...
Hillrom is a wholly owned subsidiary of Baxter and was formally part of Hill-Rom Holdings, Inc., which was formerly a part of Hillenbrand Industries until that company split its medical equipment division from their casket business in 2008. [3] Their headquarters are in Chicago, Illinois. [3] John Groetelaars was the President and CEO. [4]
This page was last edited on 28 December 2021, at 16:02 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
NEW YORK (Reuters) -Buyout firm Carlyle Group struck a deal to acquire Baxter’s kidney-care unit Vantive for $3.8 billion, the companies said on Tuesday. In 2022, Baxter started exploring ...
Baxter declined to comment while Carlyle did not immediately respond to a Reuters request for comment. ... 800-290-4726 more ways to reach us. Sign in. Mail. 24/7 Help. For premium support please ...
The largest manufacturing facility is located in Hechingen, Germany, employing approximately 1,380 people. Gambro has 350 research and development employees in four locations all over Europe. [citation needed] The company has offices and representatives in more than 100 countries. Around 350,000 chronic renal disease patients are treated with ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.